Research progress for neovascular glaucoma treatment
-
-
-
[1] 仪立群, 鞠林芳, 仲苏鄂, 等.新生血管性青光眼治疗方法和策略的研究进展[J].国际眼科杂志, 2016, 16(3): 462-465. https://www.cnki.com.cn/Article/CJFDTOTAL-GJYK201603015.htm [2] 楚启萌, 具尔提·阿不都卡地尔.抗血管内皮生长因子药物在新生血管性青光眼治疗中的应用[J].国际眼科杂志, 2016, 16(1): 63-65. https://www.cnki.com.cn/Article/CJFDTOTAL-GJYK201601017.htm [3] Woetzel A K, Lauermann J L, Kreitz K, et al. Optical coherence tomography angiography image quality assessment at varying retinal expertise levels[J]. J Curr Ophthalmol, 2018, 31(2): 161-167. http://www.sciencedirect.com/science/article/pii/S2452232518302087
[4] 孔令普, 赵宏, 陈梦平, 等.视网膜光凝联合雷珠单抗治疗新生血管性青光眼35例的临床疗效观察[J].中华眼科医学杂志, 2016, 6(2): 87-92. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYB201602007.htm [5] Yi QY, Cai B, Huang J, et al. Cyclophotocoagulation with an illuminated laser probe under a noncontact wide-angle retinoscope: A modified technique of ciliary body photocoagulation[J]. Indian J Ophthalmol, 2019, 67(4): 515-519. doi: 10.4103/ijo.IJO_65_18
[6] 石兴东, 李文博, 马腾, 等.玻璃体切割手术治疗增生型糖尿病视网膜病变的疗效观察[J].眼科新进展, 2017, 37(3): 248-250. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ201703011.htm [7] Sánchez-Tabernero S, Juberías J R, Artells N, et al. Management and Systemic Implications of Diabetic Neovascular Glaucoma[J]. Ophthalmic Res, 2019, 62(2): 111-115. doi: 10.1159/000500607
[8] 张秀兰, 王家伟.难治性青光眼的治疗策略[J].眼科, 2015, 24(3): 214-216. https://www.cnki.com.cn/Article/CJFDTOTAL-YAKE201503026.htm [9] 李秀云, 李聪伶, 邓爱军.血管内皮细胞生长因子抑制剂在新生血管性青光眼治疗中的作用[J].中国糖尿病杂志, 2015, 23(11): 987-990. doi: 10.3969/j.issn.1006-6187.2015.11.007 [10] Lu Q, Lu L, Chen B, et al. Efficacy comparison of intravitreal injections of conbercept and ranibizumab for severe proliferative diabetic retinopathy[J]. Can J Ophthalmol, 2019, 54(3): 291-296. doi: 10.1016/j.jcjo.2018.06.010
[11] Hengerer F H, Auffarth G U, Riffel C, et al. Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study[J]. Adv Ther, 2019, 36(7): 1606-1617. doi: 10.1007/s12325-019-00984-9
[12] 苏锐锋, 苏畅, 董微丽, 等.两种方法治疗新生血管性青光眼的临床观察[J].国际眼科杂志, 2019, 19(6): 1048-1051. https://www.cnki.com.cn/Article/CJFDTOTAL-GJYK201906041.htm [13] 赵茂竹, 彭洁, 张杰, 等. 3种方法治疗新生血管性青光眼的临床观察[J].中国药房, 2018, 29(6): 824-828. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYA201806024.htm [14] Torky M A, Al Zafiri Y A, Hagras S M, et al. Safety and efficacy of ultrasound ciliary plasty as a primary intervention in glaucoma patients[J]. Int J Ophthalmol, 2019, 12(4): 597-602. http://www.ncbi.nlm.nih.gov/pubmed/31024813
[15] 高传文, 陈伟, 杨潇远, 等. Ex-Press房水引流物植入术治疗新生血管性青光眼临床观察[J].眼科新进展, 2018, 38(8): 762-765. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ201808017.htm [16] Yang X, Wang C, Su G. Recent advances in the diagnosis and treatment of Coats′disease[J]. Int Ophthalmol, 2019, 39(4): 957-970. doi: 10.1007/s10792-019-01095-8
[17] 洪颖, 张纯, 王常观, 等.虹膜荧光素血管造影在新生血管性青光眼随访中的应用[J].眼科新进展, 2018, 38(9): 865-868. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ201809018.htm [18] 牛洁. TNF-α和IL-6在新生血管性青光眼发病过程中的作用[J].国际眼科杂志, 2018, 18(9): 1684-1686. https://www.cnki.com.cn/Article/CJFDTOTAL-GJYK201809034.htm [19] 邓月, 张金莎.抗VEGF药物联合PRP治疗新生血管性青光眼的效果[J].国际眼科杂志, 2018, 18(10): 1855-1858. doi: 10.3980/j.issn.1672-5123.2018.10.23 [20] Schwikkard S, Whitmore H, Sishtla K, et al. The Antiangiogenic Activity of Naturally Occurring and Synthetic Homoisoflavonoids from the Hyacinthaceae (sensu APGII)[J]. J Nat Prod, 2019, 82(5): 1227-1239. doi: 10.1021/acs.jnatprod.8b00989
[21] 洪颖, 胡运韬, 张纯, 等.新生血管性青光眼三联序贯治疗效果观察[J].眼科新进展, 2017, 37(4): 372-375. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ201704021.htm [22] 闫玮玉, 李建军, 徐亮, 等. 2014-2016年北京同仁医院青光眼专科门诊青光眼类型构成比分析[J].眼科, 2017, 26(4): 234-237. https://www.cnki.com.cn/Article/CJFDTOTAL-YAKE201704009.htm [23] Jajapuram S D, Mishra D K, Kaliki S. Choroidal schwannoma presenting with neovascular glaucoma: A report of two cases[J]. Oman J Ophthalmol, 2019, 12(2): 125-128. doi: 10.4103/ojo.OJO_123_2018
[24] 马金瑞, 律鹏, 张文芳.新生血管性青光眼不同治疗方法和疗效评价[J].国际眼科杂志, 2018, 18(12): 2173-2178. doi: 10.3980/j.issn.1672-5123.2018.12.12 [25] 蒋云.睫状体冷冻术在晚期新生血管性青光眼治疗中的应用分析[J].现代预防医学, 2011, 38(19): 4040-4041. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF201119075.htm [26] Lutic I, Dragne C, Filip M, et al. Subcyclo laser procedure results in patients with glaucoma[J]. Rom J Ophthalmol, 2018, 62(4): 296-299. doi: 10.22336/rjo.2018.45
[27] Ivanova N V, Savchenko A V. Method of preventing late hemorrhagic complications after surgical treatment of secondary neovascular glaucoma[J]. Vestn Oftalmol, 2019, 135(2): 12-15. doi: 10.17116/oftalma201913502112
[28] 刘斌, 杨玉霞, 刘杏, 等.雷珠单抗联合Ahmed青光眼阀植入术治疗新生血管性青光眼[J].眼科新进展, 2015, 35(3): 263-265. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ201503016.htm [29] 杨丽, 唐慧.雷珠单抗联合小梁切除术及全视网膜光凝治疗新生血管性青光眼的临床观察[J].眼科新进展, 2016, 36(4): 368-370. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ201604019.htm [30] 冯希敏, 赵庆新, 张凤妍.雷珠单抗联合小梁切除术及视网膜光凝术治疗新生血管性青光眼临床疗效分析[J].眼科新进展, 2018, 38(1): 80-83. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ201801019.htm [31] 姬红培, 张唯伟, 吴维.新生血管性青光眼Ahmed阀植入术后滤过泡包裹的预防[J].实用医学杂志, 2015, 31(4): 682-683. doi: 10.3969/j.issn.1006-5725.2015.04.060 [32] Tadepalli S H, Shields C L, Shields J A, et al. Intraocular medulloepithelioma - A review of clinical features, DICER 1 mutation, and management[J]. Indian J Ophthalmol, 2019, 67(6): 755-762. doi: 10.4103/ijo.IJO_845_19
[33] 龙婷, 陈佳, 杜磊, 等.雷珠单抗联合玻璃体切割术治疗糖尿病视网膜病变合并新生血管性青光眼[J].眼科新进展, 2017, 37(12): 1182-1184. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ201712024.htm [34] 何广辉, 李燕.新生血管性青光眼的临床诊疗现状[J].眼科新进展, 2014, 34(10): 997-1000. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ201410033.htm [35] 刘小毛, 延新年, 范强, 等.康柏西普联合全视网膜激光光凝治疗CRVO继发新生血管性青光眼[J].国际眼科杂志, 2018, 18(6): 1077-1080. https://www.cnki.com.cn/Article/CJFDTOTAL-GJYK201806023.htm [36] Mungale S, Dave P. A novel simplified method for managing inadvertent tube cut during aurolab aqueous drainage implant surgery for refractory glaucoma[J]. Indian J Ophthalmol, 2019, 67(5): 694-696. doi: 10.4103/ijo.IJO_1708_18
[37] Calugaru D, Calugaru M. Romanian ophthalmologists in the renowned ophthalmic journals worldwide[J]. Rom J Ophthalmol, 2018, 62(4): 260-269. doi: 10.22336/rjo.2018.40
[38] Oxenreiter M M, Lane A M, Jain P, et al. Conservative management of suspicious melanocytic lesions of the iris[J]. Graefes Arch Clin Exp Ophthalmol, 2019, 257(6): 1319-1324. doi: 10.1007/s00417-019-04296-0
[39] 史志洁, 张金嵩, 吕晓贝.玻璃体内注射康柏西普联合手术治疗伴玻璃体积血的新生血管性青光眼[J].眼科新进展, 2016, 36(8): 751-754. https://www.cnki.com.cn/Article/CJFDTOTAL-XKJZ201608015.htm [40] 丰枫, 谭璇.新生血管性青光眼手术患者快速康复理念下的疼痛管理[J].护理学杂志, 2018, 33(16): 24-27. doi: 10.3870/j.issn.1001-4152.2018.16.024
计量
- 文章访问数: 155
- HTML全文浏览量: 138
- PDF下载量: 9
下载:
苏公网安备 32100302010246号
